About University of San Francisco, Sandler Neurosciences Center-Site Number:8400137
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at University of San Francisco, Sandler Neurosciences Center-Site Number:8400137
During the past decade, University of San Francisco, Sandler Neurosciences Center-Site Number:8400137 conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
REsearching Coronary REduction by Appropriately Targeting Euglycemia (RECREATE Pilot Study)
2008-04-01
2010-06-01
Completed
500
Secondary Prevention of coRonary Events After Discharge From Hospital (SPREAD)
2011-08-01
2013-08-01
Completed
806
Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)
2014-11-27
2018-08-14
Completed
5,390
Study of a Quality Improvement Toolkit in Kerala, India, Among Hospitals Treating Acute Coronary Syndrome Patients
2014-11-01
2017-12-01
Completed
21,374
A Clinical Trial Comparing Efficacy and Safety of Dabigatran Etexilate With Warfarin in Patients With Cerebral Venous and Dural Sinus Thrombosis (RE-SPECT CVT)
2016-12-13
2018-06-22
Completed
120
Aldosterone bloCkade for Health Improvement EValuation in End-stage Renal Disease
2017-07-07
2025-01-01
Recruiting
2,750
EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)
2019-09-20
2024-04-01
Recruiting
1,200
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at University of San Francisco, Sandler Neurosciences Center-Site Number:8400137
According to Clinical.Site data, the most researched conditions in "University of San Francisco, Sandler Neurosciences Center-Site Number:8400137" are
"Primary Progressive Multiple Sclerosis" (1 trials), "Relapsing Multiple Sclerosis" (1 trials) and "Secondary Progressive Multiple Sclerosis" (1 trials). Many other conditions were trialed in "University of San Francisco, Sandler Neurosciences Center-Site Number:8400137" in a lesser frequency.
Clinical Trials Intervention Types at University of San Francisco, Sandler Neurosciences Center-Site Number:8400137
Most popular intervention types in "University of San Francisco, Sandler Neurosciences Center-Site Number:8400137" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Tolebrutinib" (3 trials), "Placebo to match Tolebrutinib" (2 trials), "Placebo" (1 trials), "Placebo to match Teriflunomide" (1 trials) and "Teriflunomide HMR1726" (1 trials). Other intervention names were less common.
Clinical Trials Genders at University of San Francisco, Sandler Neurosciences Center-Site Number:8400137
The vast majority of trials in "University of San Francisco, Sandler Neurosciences Center-Site Number:8400137" are
3 trials for "All" genders.
Clinical Trials Status at University of San Francisco, Sandler Neurosciences Center-Site Number:8400137
Currently, there are NaN active trials in "University of San Francisco, Sandler Neurosciences Center-Site Number:8400137".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in University of San Francisco, Sandler Neurosciences Center-Site Number:8400137,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in University of San Francisco, Sandler Neurosciences Center-Site Number:8400137, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".